Physician

Jacqueline Marie Selph, M.D.

According to 2025 Medicare claims, Jacqueline Selph, M.D. (NPI: 1609219039) practices dermatology in the Asheville, NC market, with the plurality of this provider's patient population coming from Henderson, NC. This provider's primary affiliated billing organization is HENDERSONVILLE DERMATOLOGY, PLLC (NPI: 1770949398; TIN: 811000278) and primary practice location at 28731-8529.

Selph's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,456 traditional Medicare patients, billed 9,507 HCPCS/CPT codes, and received $624,436 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,017 prescription claims across 506 beneficiaries totaling $335,437 in drug costs, led by Humira Pen (Adalimumab). Open Payments data shows 31 records totaling $668. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $25,798 to $624,436. Similarly, Part D prescription costs have risen steadily, from $11,785 to $335,437. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$312K$624K2018 Medicare payment: $25,798 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $84,195 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $217,315 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $364,779 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $379,910 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $411,193 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $624,436 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018119485$25,798
20193571,470$84,195
20206743,665$217,315
20218494,870$364,779
20221,0405,535$379,910
20231,0466,107$411,193
20241,4569,507$624,436

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$195K$391K2015 Drug cost: $11,785 (USD; Tot_Drug_Cst)2016 Drug cost: $73,654 (USD; Tot_Drug_Cst)2017 Drug cost: $36,797 (USD; Tot_Drug_Cst)2018 Drug cost: $59,257 (USD; Tot_Drug_Cst)2019 Drug cost: $84,175 (USD; Tot_Drug_Cst)2020 Drug cost: $85,084 (USD; Tot_Drug_Cst)2021 Drug cost: $119,173 (USD; Tot_Drug_Cst)2022 Drug cost: $301,853 (USD; Tot_Drug_Cst)2023 Drug cost: $390,722 (USD; Tot_Drug_Cst)2024 Drug cost: $335,437 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154482$11,785
2016116211$73,654
201799214$36,797
2018100219$59,257
2019149325$84,175
2020230492$85,084
2021286576$119,173
2022346793$301,853
2023375830$390,722
20245061,017$335,437

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more423539$87
11102Biopsy of related skin growth, first growth457538$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,1071,461$59
17000Destruction of precancer skin growth, 1 growth8571,089$36
17003Destruction of precancer skin growth, 2-14 growths5883,098$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira PenAdalimumab15420$106,539
OtezlaApremilast13390$73,894
Clobetasol PropionateClobetasol Propionate1283,406$5,970
Triamcinolone AcetonideTriamcinolone Acetonide1965,913$2,303
FluorouracilFluorouracil26643$1,531

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$668SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jacqueline Marie Selph, M.D.?

Tedicare shows public-source Medicare data for Jacqueline Marie Selph, M.D. (NPI 1609219039), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jacqueline Marie Selph, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jacqueline Marie Selph, M.D.?

Jacqueline Marie Selph, M.D. is linked to HENDERSONVILLE DERMATOLOGY, PLLC (billing NPI 1770949398) in the available physician profile data.

Does Jacqueline Marie Selph, M.D. have Open Payments data?

Jacqueline Marie Selph, M.D. has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.